Table 5 Correlation of osteocalcin and CVAI with ASCVD risk.

From: Osteocalcin and Chinese visceral adiposity index are associated with the risk of ASCVD and arterial stiffness in patients with T2DM

Model

 

Male

Female

Standardized Beta

P value

OR

95% CI

P value

Standardized Beta

P value

OR

95% CI

P value

Crude Model

OC

-0.13

 < 0.05

0.98

(0.95,1.01)

0.2

-0.02

0.3

0.99

(0.91,1.07)

0.3

 

CVAI

0.15

 < 0.05

1.01

(1.00,1.02)

0.1

0.29

0

1.04

(1.02,1.07)

 < 0.05

Model 1

OC

-0.07

 < 0.05

0.97

(0.94,1.00)

 < 0.05

-0.05

0.4

0.95

(0.86,1.05)

0.3

 

CVAI

0.01

0.9

1.01

(1.00,1.02)

0.1

0.29

0

1.05

(1.02,1.08)

 < 0.05

Model 2

OC

-0.07

 < 0.05

0.97

(0.94,1.00)

 < 0.05

-0.03

0.1

0.97

(0.85,1.09)

0.1

 

CVAI

0.004

0.9

1.01

(1.00,1.02)

0.1

0.29

0

1.05

(1.02,1.08)

 < 0.05

Model 3

OC

-0.08

 < 0.05

0.96

(0.92,0.99)

 < 0.05

-0.07

 < 0.05

0.93

(0.83,1.05)

 < 0.05

 

CVAI

0.02

0.7

1.01

(1.00,1.02)

 < 0.05

0.26

0

1.08

(1.02,1.14)

 < 0.05

Model 4

OC

-0.08

 < 0.05

0.96

(0.92,1.00)

 < 0.05

-0.03

 < 0.05

0.93

(0.8,1.08)

 < 0.05

 

CVAI

0.01

 < 0.05

1.01

(1.00,1.02)

 < 0.05

0.25

0

1.08

(1.02,1.14)

 < 0.05

  1. OC: osteocalcin; CVAI: China visceral index. Crude Model: Controlled menopause status for women; Model 1: Controlled traditional cardiovascular risk factors + osteocalcin or CVAI; Model 2: Controlled traditional cardiovascular risk factors + osteocalcin + CVAI; Model 3: Controlled traditional cardiovascular risk factors + statin use + Ca + HOMA-β + osteocalcin or CVAI; Model 4: Controlled traditional cardiovascular risk factors + statin use + Ca + HOMA-β + osteocalcin + CVAI. Traditional cardiovascular risk factors: current smoking (male), menopausal status, (female), hypertension, antihypertensive therapy, ASCVD history, and HDL.
Back to article page